{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T20:53:23Z","timestamp":1792356803026,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00432-019-02999-9","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T18:02:44Z","timestamp":1565719364000},"page":"2595-2604","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The role of autologous stem cell transplantation in peripheral T cell lymphoma: a long-term follow-up single-center experience"],"prefix":"10.1007","volume":"145","author":[{"given":"Malte","family":"Roerden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6404-7391","authenticated-orcid":false,"given":"Juliane S.","family":"Walz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"S\u00f6kler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Federmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Kanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Bethge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wichard","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"key":"2999_CR1","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1002\/1097-0142(19800601)45:11<2843::AID-CNCR2820451121>3.0.CO;2-C","volume":"45","author":"S Advani","year":"1980","unstructured":"Advani S et al (1980) Immune dysfunction in non-Hodgkin\u2019s lymphoma. Cancer 45:2843\u20132848","journal-title":"Cancer"},{"key":"2999_CR2","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1182\/blood.V79.5.1193.1193","volume":"79","author":"W Brugger","year":"1992","unstructured":"Brugger W, Bross K, Frisch J, Dern P, Weber B, Mertelsmann R, Kanz L (1992) Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin [see comments]. Blood 79:1193\u20131200","journal-title":"Blood"},{"key":"2999_CR3","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1080\/10428194.2017.1300888","volume":"58","author":"H Cederleuf","year":"2017","unstructured":"Cederleuf H et al (2017) Outcome of peripheral T cell lymphoma in first complete remission: a Danish\u2013Swedish population-based study. Leuk Lymphoma 58:2815\u20132823","journal-title":"Leuk Lymphoma"},{"key":"2999_CR4","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD et al (1999) Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. J Clin Oncol 17:1244","journal-title":"J Clin Oncol"},{"key":"2999_CR5","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/bjh.14477","volume":"176","author":"D Chihara","year":"2017","unstructured":"Chihara D et al (2017) The survival outcome of patients with relapsed\/refractory peripheral T cell lymphoma-not otherwise specified and angioimmunoblastic T cell lymphoma. Br J Haematol 176:750\u2013758. \n                    https:\/\/doi.org\/10.1111\/bjh.14477","journal-title":"Br J Haematol"},{"key":"2999_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/oxfordjournals.annonc.a057673","volume":"1","author":"B Coiffier","year":"1990","unstructured":"Coiffier B, Brousse N, Peuchmaur M, Berger F, Gisselbrecht C, Bryon P, Diebold J (1990) Peripheral T cell lymphomas have a worse prognosis than B cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. Ann Oncol 1:45\u201350","journal-title":"Ann Oncol"},{"key":"2999_CR7","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1200\/JCO.2004.12.050","volume":"22","author":"P Corradini","year":"2004","unstructured":"Corradini P et al (2004) Graft-versus-lymphoma effect in relapsed peripheral T cell non-Hodgkin\u2019s lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells. J Clin Oncol 22:2172\u20132176","journal-title":"J Clin Oncol"},{"key":"2999_CR8","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.leu.2404306","volume":"20","author":"P Corradini","year":"2006","unstructured":"Corradini P et al (2006) Long-term follow-up of patients with peripheral T cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia 20:1533","journal-title":"Leukemia"},{"issue":"11","key":"2999_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1182\/blood.V108.11.2723.2723","volume":"108","author":"F d\u2019Amore","year":"2006","unstructured":"d\u2019Amore F et al (2006) Dose-dense induction followed by autologous stem cell transplant (ASCT) as 1st line treatment in peripheral T cell lymphomas (PTCL)-a phase II Study of the Nordic Lymphoma Group (NLG). Blood 108(11):401","journal-title":"Blood"},{"key":"2999_CR10","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","volume":"30","author":"F d\u2019Amore","year":"2012","unstructured":"d\u2019Amore F et al (2012) Up-front autologous stem-cell transplantation in peripheral T cell lymphoma: NLG-T-01. J Clin Oncol 30:3093\u20133099","journal-title":"J Clin Oncol"},{"key":"2999_CR11","doi-asserted-by":"publisher","first-page":"v108","DOI":"10.1093\/annonc\/mdv201","volume":"26","author":"F d\u2019Amore","year":"2015","unstructured":"d\u2019Amore F et al (2015) Peripheral T cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 26:v108\u2013v115","journal-title":"Ann Oncol"},{"key":"2999_CR12","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1002\/cncr.25377","volume":"116","author":"G Dueck","year":"2010","unstructured":"Dueck G et al (2010) Interim report of a phase 2 clinical trial of lenalidomide for T cell non-Hodgkin lymphoma. Cancer 116:4541\u20134548","journal-title":"Cancer"},{"key":"2999_CR13","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood-2014-04-573089","volume":"124","author":"F Ellin","year":"2014","unstructured":"Ellin F, Landstrom J, Jerkeman M, Relander T (2014) Real-world data on prognostic factors and treatment in peripheral T cell lymphomas: a study from the Swedish Lymphoma Registry. Blood 124:1570\u20131577. \n                    https:\/\/doi.org\/10.1182\/blood-2014-04-573089","journal-title":"Blood"},{"key":"2999_CR14","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1200\/JCO.2013.54.2456","volume":"32","author":"MA Fanale","year":"2014","unstructured":"Fanale MA et al (2014) Brentuximab vedotin in the front-line treatment of patients with CD30+\u2009peripheral T cell lymphomas: results of a phase I study. J Clin Oncol 32:3137","journal-title":"J Clin Oncol"},{"key":"2999_CR15","doi-asserted-by":"publisher","first-page":"6756","DOI":"10.1182\/blood-2010-05-231548","volume":"117","author":"FM Foss","year":"2011","unstructured":"Foss FM, Zinzani PL, Vose JM, Gascoyne RD, Rosen ST, Tobinai K (2011) Peripheral T cell lymphoma. Blood 117:6756\u20136767. \n                    https:\/\/doi.org\/10.1182\/blood-2010-05-231548","journal-title":"Blood"},{"key":"2999_CR16","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/annonc\/mdx787","volume":"29","author":"G Fossard","year":"2017","unstructured":"Fossard G et al (2017) Role of up-front autologous stem-cell transplantation in peripheral T cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers. Ann Oncol 29:715\u2013723","journal-title":"Ann Oncol"},{"key":"2999_CR17","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1182\/blood-2007-02-074641","volume":"110","author":"A Gallamini","year":"2007","unstructured":"Gallamini A et al (2007) Alemtuzumab (campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. Blood 110:2316\u20132323","journal-title":"Blood"},{"key":"2999_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.critrevonc.2013.08.016","volume":"89","author":"M Gkotzamanidou","year":"2014","unstructured":"Gkotzamanidou M, Papadimitriou CA (2014) Peripheral T cell lymphoma: the role of hematopoietic stem cell transplantation. Crit Rev Oncol\/Hematol 89:248\u2013261","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"2999_CR19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/annonc\/mdq359","volume":"22","author":"G Guti\u00e9rrez-Garc\u00eda","year":"2010","unstructured":"Guti\u00e9rrez-Garc\u00eda G et al (2010) Comparison of four prognostic scores in peripheral T cell lymphoma. Ann Oncol 22:397\u2013404","journal-title":"Ann Oncol"},{"key":"2999_CR20","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1182\/blood.V83.12.3787.3787","volume":"83","author":"R Haas","year":"1994","unstructured":"Haas R et al (1994) Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83:3787\u20133794","journal-title":"Blood"},{"key":"2999_CR21","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.bbmt.2008.01.002","volume":"14","author":"M Hamadani","year":"2008","unstructured":"Hamadani M, Awan FT, Elder P, Lin TS, Porcu P, Blum KA, Devine SM (2008) Allogeneic hematopoietic stem cell transplantation for peripheral T cell lymphomas; evidence of graft-versus-T cell lymphoma effect. Biol Blood Marrow Transplant 14:480\u2013483","journal-title":"Biol Blood Marrow Transplant"},{"key":"2999_CR22","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1182\/blood-2013-12-542142","volume":"123","author":"SM Horwitz","year":"2014","unstructured":"Horwitz SM et al (2014) Objective responses in relapsed T cell lymphomas with single agent brentuximab vedotin. Blood 123:3095\u20133100. \n                    https:\/\/doi.org\/10.1182\/blood-2013-2012-542142","journal-title":"Blood"},{"key":"2999_CR23","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1046\/j.1365-2141.2000.02244.x","volume":"110","author":"C Jacquy","year":"2000","unstructured":"Jacquy C et al (2000) A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin\u2019s lymphoma: one-half of patients significantly mobilize malignant cells. Br J Haematol 110:631\u2013637","journal-title":"Br J Haematol"},{"key":"2999_CR24","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbmt.2013.01.006","volume":"19","author":"JA Kanakry","year":"2013","unstructured":"Kanakry JA et al (2013) Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma. Biol Blood Marrow Transplant 19:602\u2013606. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2013.01.006","journal-title":"Biol Blood Marrow Transplant"},{"key":"2999_CR25","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.bbmt.2017.07.027","volume":"23","author":"MA Kharfan-Dabaja","year":"2017","unstructured":"Kharfan-Dabaja MA et al (2017) Clinical practice recommendations on indication and timing of hematopoietic cell transplantation in mature T cell and NK\/T cell lymphomas: an international collaborative effort on behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 23:1826\u20131838","journal-title":"Biol Blood Marrow Transplant"},{"key":"2999_CR26","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1200\/JCO.2007.14.1366","volume":"26","author":"S Le Gouill","year":"2008","unstructured":"Le Gouill S et al (2008) Graft-versus-lymphoma effect for aggressive T cell lymphomas in adults: a study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire. J Clin Oncol 26:2264\u20132271. \n                    https:\/\/doi.org\/10.1200\/jco.2007.14.1366","journal-title":"J Clin Oncol"},{"key":"2999_CR27","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1200\/JCO.2012.44.7524","volume":"31","author":"V Mak","year":"2013","unstructured":"Mak V et al (2013) Survival of patients with peripheral T cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors. J Clin Oncol 31:1970\u20131976","journal-title":"J Clin Oncol"},{"key":"2999_CR28","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1182\/blood-2013-12-516245","volume":"123","author":"AJ Moskowitz","year":"2014","unstructured":"Moskowitz AJ, Lunning M, Horwitz SM (2014) How I treat the peripheral T cell lymphomas. Blood 123:2636\u20132644. \n                    https:\/\/doi.org\/10.1182\/blood-2013-2012-516245","journal-title":"Blood"},{"key":"2999_CR29","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1093\/annonc\/mdp211","volume":"20","author":"M Nickelsen","year":"2009","unstructured":"Nickelsen M et al (2009) High-dose CHOP plus etoposide (MegaCHOEP) in T cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). Ann Oncol 20:1977\u20131984","journal-title":"Ann Oncol"},{"key":"2999_CR30","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T et al (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin\u2019s lymphoma. N Engl J Med 333:1540\u20131545","journal-title":"N Engl J Med"},{"key":"2999_CR31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11899-010-0062-x","volume":"5","author":"PP Piccaluga","year":"2010","unstructured":"Piccaluga PP, Agostinelli C, Gazzola A, Mannu C, Bacci F, Sabattini E, Pileri SA (2010) Prognostic markers in peripheral T cell lymphoma. Curr Hematol Malig Rep 5:222\u2013228","journal-title":"Curr Hematol Malig Rep"},{"key":"2999_CR32","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.1182\/blood-2010-10-312603","volume":"117","author":"RL Piekarz","year":"2011","unstructured":"Piekarz RL et al (2011) Phase 2 trial of romidepsin in patients with peripheral T cell lymphoma. Blood 117:5827\u20135834","journal-title":"Blood"},{"key":"2999_CR33","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"Project IT-CL","year":"2008","unstructured":"Project IT-CL (2008) International peripheral T cell and natural killer\/T cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26:4124\u20134130. \n                    https:\/\/doi.org\/10.1200\/jco.2008.16.4558","journal-title":"J Clin Oncol"},{"key":"2999_CR34","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1200\/JCO.2008.17.4870","volume":"27","author":"P Reimer","year":"2009","unstructured":"Reimer P et al (2009) Autologous stem-cell transplantation as first-line therapy in peripheral T cell lymphomas: results of a prospective multicenter study. J Clin Oncol 27:106\u2013113","journal-title":"J Clin Oncol"},{"key":"2999_CR35","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/annonc\/mdl466","volume":"18","author":"J Rodriguez","year":"2007","unstructured":"Rodriguez J et al (2007) The results of consolidation with autologous stem-cell transplantation in patients with peripheral T cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience. Ann Oncol 18:652\u2013657","journal-title":"Ann Oncol"},{"key":"2999_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1600-0609.2007.00856.x","volume":"79","author":"J Rodr\u00edguez","year":"2007","unstructured":"Rodr\u00edguez J et al (2007) Frontline autologous stem cell transplantation in high-risk peripheral T cell lymphoma: a prospective study from The Gel-Tamo Study Group. Eur J Haematol 79:32\u201338","journal-title":"Eur J Haematol"},{"key":"2999_CR37","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00277-018-3288-7","volume":"97","author":"S Rohlfing","year":"2018","unstructured":"Rohlfing S et al (2018) The impact of stem cell transplantation on the natural course of peripheral T cell lymphoma: a real-world experience. Ann Hematol 97:1241\u20131250. \n                    https:\/\/doi.org\/10.1007\/s00277-018-3288-7","journal-title":"Ann Hematol"},{"key":"2999_CR38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","volume":"17","author":"M Schemper","year":"1996","unstructured":"Schemper M, Smith TL (1996) A note on quantifying follow-up in studies of failure time. Contemp Clin Trials 17:343\u2013346","journal-title":"Contemp Clin Trials"},{"key":"2999_CR39","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1200\/JCO.2012.46.0188","volume":"31","author":"SM Smith","year":"2013","unstructured":"Smith SM et al (2013) Hematopoietic cell transplantation for systemic mature T cell non-Hodgkin lymphoma. J Clin Oncol 31:3100","journal-title":"J Clin Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-019-02999-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-019-02999-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-019-02999-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T23:28:14Z","timestamp":1597188494000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-019-02999-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["2999"],"URL":"https:\/\/doi.org\/10.1007\/s00432-019-02999-9","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,13]]},"assertion":[{"value":"3 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}